![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.prnewswire.com/news-releases/fosun-pharmas-self-developed-artemisinin-medicines-inject-new-impetus-to-malaria-prevention-and-treatment-in-africa-302128373.html
https://www.globenewswire.com/news-release/2021/08/24/2285409/0/en/PULMOHEAL-ARTIVEDA-IS-CLINICALLY-ACTIVE-AGAINST-MILD-AND-MODERATE-COVID-19.html
https://www.globenewswire.com/news-release/2021/04/01/2203466/0/en/Manus-Bio-Awarded-Additional-Funding-to-Support-its-Artemisinin-Development-Program.html
https://www.proactiveinvestors.com.au/companies/news/930059/mgc-pharmaceuticals-expands-artemic-phase-ii-clinical-trial-on-covid-19-patients-in-israel-and-india-930059.html
https://www.biospace.com/article/releases/mateon-and-asili-research-alliance-enter-into-partnership-for-the-development-of-artemisinin-against-covid-19/
https://www.globenewswire.com/news-release/2020/07/13/2061115/0/en/Mateon-Therapeutics-to-fund-observational-studies-of-Artemisinin-in-developing-countries.html
http://investor.mateon.com/news-releases/news-release-details/mateon-expands-its-covid-19-therapeutic-program-include
https://www.in-pharmatechnologist.com/Article/2019/09/19/Darmerica-recalls-two-lots-of-quinacrine
https://www.pharmacompass.com/pdf/news/darmerica-llc-issues-voluntary-nationwide-recall-of-quinacrine-dihydrochloride-due-to-a-labeling-error-1568954122.pdf
https://phytonbiotech.com/phyton-biotech-wins-grant-develop-new-approaches-manufacturing-artemisinin-2/